The impact of antenatal factor XIII levels on postpartum haemorrhage: a prospective observational study
- 17 Downloads
Postpartum haemorrhage (PPH) is a leading cause of maternal mortality and morbidity. Our aim was to investigate the relationships between antenatal factor XIII (FXIII), fibrinogen levels, and blood loss at childbirth.
This prospective observational study evaluated an unselected cohort of pregnant women admitted for intended vaginal deliveries of singletons at term. To determine clotting factor levels, we obtained blood samples at a maximum of three days prior to vaginal delivery. A calibrated collecting drape was used to quantify blood loss in the third stage of labour. Moderate and severe PPH were diagnosed as blood losses ≥ 500 mL and ≥ 1000 mL, respectively. In a multiple logistic regression analysis, we determined whether coagulation factors and their interactions could independently predict (severe) PPH.
We analysed 548 vaginal deliveries that occurred during the study period. Of those, 78 (14.2%) lost ≥ 500 mL and 18 (3.3%) lost ≥ 1000 mL of blood. The mean pre-delivery FXIII activity in women with PPH (79.33% ± 15.5) was significantly (p < 0.001) lower than in women without PPH (86.45% ± 14.6). A receiver operating characteristic curve analysis detected antenatal FXIII cutoff levels of 83.5% and 75.5% for PPH and severe PPH, respectively. The multiple logistic regression analysis showed that FXIII alone (p < 0.001) and its interaction with fibrinogen (p = 0.03) significantly predicted PPH. FXIII was not significantly correlated with blood loss among patients with severe PPH.
Our results suggested that antenatal FXIII levels may have a significant influence on PPH. The interaction between FXIII and fibrinogen might also provide slight advantages in forecasting PPH.
KeywordsFactor XIII Fibrinogen Postpartum blood loss Postpartum haemorrhage
CB: manuscript writing, data analysis, LM: manuscript writing, data collection, AH: data collection, KND: data collection, LK: manuscript editing, CvH: manuscript editing, WH: project development, FP: data analysis.
This study was funded by CSL Behring.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest related to this study. Trial registration: German Clinical Trials Register (7873).
- 9.Wettstein P, Haeberli A, Stutz M et al (2004) Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 99:1564–1569 (table of contents) Google Scholar
- 20.Organization WH (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhageGoogle Scholar
- 21.DGGG (2016) Peripartale Blutungen, Diagnostik und Therapie. Deutsche Gesellschaft für Gynäkologie und GeburtshilfeGoogle Scholar
- 30.Cantwell R, Clutton-Brock T, Cooper G et al (2011) Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118(Suppl 1):1–203Google Scholar